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160 W.S. El-Shimy et al.groups. Group I included twenty patients who were extubated and received non-invasive ventila-
tion. Group II included twenty patients who were reconnected to the ventilator and continued
weaning with synchronized intermittent mandatory ventilation with pressure support.
Results: The duration of weaning was signiﬁcantly short in group I compared to group II
(35 ± 1.63 versus 47 ± 2.25 hours) (p= 0.044), duration of ICU stay was signiﬁcantly shorter
in group I compared to group II (9.50 ± 3.2 versus 11.4 ± 2.70 days) (p= 0.049). While the num-
ber of deaths in ICU was signiﬁcantly higher (5; 25%) in group II compared to (3; 15%) group I
(p= 0.031) and the number of deaths at 30 days was signiﬁcantly higher (9; 45%) in group II com-
pared to (5; 25%) group I (p= 0.008).
Conclusions: Noninvasive positive pressure ventilation permits earlier removal of the endotra-
cheal tube, reduces weaning time, stay in the intensive care unit, decreases the incidence of nosoco-
mial pneumonia and improves 30 day survival rates.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
Open access under CC BY-NC-ND license.Introduction
Chronic obstructive pulmonary disease (COPD) is a disease
with an increasing prevalence and mortality worldwide [1].
Mechanical ventilation (MV) is often life-saving when patients
with COPD experience acute respiratory compromise [2,3].
Invasive ventilation is associated with numerous complications
including airway injury, higher risk for gastrointestinal bleed-
ing, thromboembolism, barotrauma, and ventilator-associated
pneumonia [4].
Weaning has been deﬁned as the process whereby mechan-
ical ventilation is gradually withdrawn and the patient resumes
spontaneous breathing [5].
Synchronized intermittent mandatory ventilation is the ﬁrst
alternative to T-tube trials, is now a frequently used mode to
wean patients off the ventilator. It involves a gradual reduction
in the amount of support being provided by the ventilator,
there is no disconnection from the ventilator [6]. One of the
most important advantages of synchronized intermittent man-
datory ventilation with pressure support (SIMV-PS) is the
reduction in the need for sedation during the weaning process
[7].
The combination of early extubation and non invasive po-
sitive pressure ventilation (NPPV) is a good alternative for
ventilation in a group of heterogeneous patients who initially
failed weaning [5].
Aim of the work
The aim of the present study was to evaluate the effectiveness
of non invasive ventilation as a weaning method in COPD pa-
tients on mechanical ventilation in comparison to conventional
mode SIMV with pressure support (SIMV-PS).
Patients and methods
This study was conducted in the ICU ward in the Chest and
Anesthesiology Departments, Tanta University Hospital on
40 mechanically ventilated patients having COPD with acute
exacerbation and respiratory failure from June 2011 to Janu-
ary 2012. This study was approved by the research ethics com-
mittee; Quality Assurance Unit, Faculty of Medicine, Tanta
University.Inclusion criteria
Mechanically ventilated COPD patients who meet the criteria
to proceed with a weaning attempt. Those patients who failed
at 30 min [5] to 2 h [8] of spontaneous breathing T piece trial
(SBT) were included in this study.
Exclusion criteria
Patients with any contraindication for non invasive positive
pressure ventilation (NIPPV) were excluded from the study:
fascial or cranial trauma or surgery, recent gastric or esopha-
geal surgery, active upper gastrointestinal bleeding, and exces-
sive amount of respiratory secretions.
The following was done to all patients
All patients were initially ventilated with control/assist control
mode, intubation was done through the orotracheal route.
Muscle relaxants and sedation were used as required. Standard
ventilator settings for COPD i.e., respiratory rate of 12/min, ti-
dal volume 8–10 mL/kg, FIO2 to obtain a saturation of 90%,
and an I:E ratio of 1:4 were initiated. With the endotracheal
tube in place, T-piece weaning trial was given to the patients
who had the following criteria:
1. Improvement of the cause of acute respiratory failure that
led to use of mechanical ventilation.
2. Correction of arterial hypoxemia (PaO2 >60 mm Hg).
3. Fraction of inspired oxygen (FIO2) 640%.
4. No fever (P38 C) or hypothermia (<35 C).
5. No need for vasoactive drugs.
6. Normal consciousness (Glasgow coma score P13) with no
need for sedative agents.
Criteria of SBT trial failure
Spontaneous breathing trial (SBT) failure was considered
when the patient had any of the following:
1. Respiratory frequency (f) >35/min.
2. Rapid shallow breathing index (RSBI) >105 breaths/liter/
min.
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try of less than 90%.
4. Heart rate >140 or <50/min.
5. Systolic blood pressure >180 or <70 mm Hg.
6. Decreased consciousness, agitation or diaphoresis.
7. Thoracic-abdominal paradoxical movement.
Immediately after T-piece failure patients were put back on
CMV/ACV mode until previous ABG values were reached (be-
fore spontaneous breathing trial) and then considered for the
respective modality of weaning.
If signs of spontaneous breathing trial failure appeared, patients
were divided into two groups according to the type of weaning
Group I (NIV group): Twenty patients were extubated and re-
ceived NIV (non-invasive ventilation) using a BiPAP ventila-
tory support system.(RESMED, Sullivan-VPAP ST-II).
Patients received NIV via an oronasal mask continuously ex-
cept during meals and for expectoration. A particular level
of IPAP (inspiratory positive airway pressure) according to pa-
tient tolerance (10–20 cm H2O) and EPAP (expiratory positive
airway pressure) (5 cm H2O) [9] that achieved satisfactory
blood gases and a respiratory rate <30/min were used. Once
that was achieved, the pressure support was decreased by
2 cm H2O every 4 h with a good tolerance and with close mon-
itoring for any change in oxygen saturation and respiratory
rate.
As soon as we could reduce the IPAP and EPAP levels to 8
and 4 cm H2O respectively, with a satisfactory ABG of
PHP 7.35, SaO2P 90%, FiO2 6 40% and RR< 30/min,
patients were allowed to breathe spontaneously; when NIV
failed, reintubation was done.
Group II (SIMV-PS group): Twenty patients were recon-
nected to the ventilator and continued weaning with conven-
tional-weaning mode (SIMV-PS) using mechanical ventilator
(Galleio and RAPHAEL Hamilton medical AG. Switzer-
land). They received SIMV with a respiratory rate of 14/
min, starting with pressure support of 20 cm H2O and tidal
volume 8–10 mL/kg. Once satisfactory blood gases were
achieved, an RR <30/min the pressure support was de-
creased by 2 cm of H2O every 4 h alternatively with a reduc-
tion of respiratory rate by 2 cycles/min with a good
tolerance and with close monitoring for any change in oxy-
gen saturation and respiratory rate.
All patients were assessed by
(1) Arterial blood gas analysis: ABG was performed at pre-
sentation and at 1, 4, 8 h during the weaning process.
Arterial blood samples were collected from each patient
by the use of disposable sterilized plastic syringe
(2) Glasgow coma Scale (GCS): It was assessed before
spontaneous breathing trial as a weaning parameter.
(3) Rapid shallow breathing index (RSBI): The RSBI was
determined before weaning, (immediately when patients
breathed room air spontaneously through the T piece).
The rapid shallow breathing index (RSBI) is a weaning
parameter usually measured at the start of a spontane-
ous breathing trial (SBT) [10].(4) Duration of weaning in hours: After randomization in
group I after extubation and receiving NIV while in
group II after reconnection to the ventilator and contin-
ued weaning with conventional-weaning mode (SIMV-
PS).
(5) Duration of ICU stay: From the day of admission to the
day of discharge from ICU.
(6) Mortality at discharge from ICU (number of deaths in
the ICU) and after 30 days.
(7) Incidence of nosocomial pneumonia and ventilator associ-
ated pneumonia (VAP): deﬁned as the presence of new
and persistent (>48 h) lung inﬁltrates on chest radiogra-
phy combined with fever, total leukocyte count (TLC)
>10.000 after 48 h on ventilator.
(8) Complications related to mode of ventilation.
Success of weaning: was assessed after 2 h of spontaneous
breathing when the patient maintained arterial oxygen satura-
tion P90% on FIO2 less than 40%, PH >7.35, respiratory
rate less than 30/min with no dyspnea and intact cognition.
Absence of even one of these criteria was considered as wean-
ing failure. Weaning failure was also considered if the patient
could not be taken off the ventilator after 30 days or needed
reintubation within 72 h of disconnection from the ventilator,
or if death related to mechanical ventilation occurred [8].
Statistical analysis
Statistical presentation and analysis of the present study were
conducted, using the mean, standard deviation and Kaplan–
Meier analysis, univariate analysis, multivariate analysis by
SPSS V.16.
Results
There was no signiﬁcant statistical difference between the two
groups regarding criteria of ﬁtness for spontaneous breathing
trial Figs. 1 and 2 Table 1 (Table 2).
Parameters of the studied groups during spontaneous breathing
trial failure (Table 3)
Twelve patients of group I and 13 of group II were able to
complete the test within 30 min and failed in the next
30 min, whereas 8 patients of group I and 7 of group II failed
before 30 min. No signiﬁcant statistical difference was found
between the 2 groups.
Serial arterial ABG at 0, 1, 2, 4, and 8 h from the start of
weaning in the two treatment groups was done and revealed
that there was no signiﬁcant statistical difference between the
two studied groups.
Weaning outcome variables in the two studied groups
Table 4 shows weaning outcome variables which revealed that
the duration of weaning was signiﬁcantly short in group I com-
pared to group II (35 ± 1.63 versus 47 ± 2.25) hours
(p= 0.044), duration of ICU stay was signiﬁcantly short in
Total patients (n=140)
MV(direct intubation) (n=40)NIV (n=100)
Total CMV 
(n=65)
CMV (n=60)
T-piece trial
Failure (n=40)
Randomized
SIMV with PS(n=20) NIV (n=20)
Success (n=20) excluded 
from the study
5 died immediately
During intubation 
Outcome
25 patients needed 
MV
Figure 1 A ﬂow chart shows patients included in this study.
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Figure 2 Kaplan–Meier curves for survivor patients within
30 days after entry into the protocol. In the overall population, the
cumulative survival probability was signiﬁcantly higher in the
noninvasive (solid lines) ventilation group than in the conven-
tional-weaning group (dashed lines) (log rank test). Time denotes
days after patients were entered into the study (after randomiza-
tion into two groups).
162 W.S. El-Shimy et al.group I compared to group II (9.50 ± 3.2 versus 11.4 ± 2.70)
days (p= 0.049). While the number of deaths in ICU was sig-
niﬁcantly higher (5; 25%) in group II compared to (3; 15%)
group I (p= 0.031) and the number of deaths at 30 days
was signiﬁcantly higher (9; 45%) in group II compared to (5;
25%) group I (p= 0.008).
Causes of death within 30 days after entry in the study
The causes that led to death within 30 days after entry in the
study included refractory hypoxemia in one patient (5%), car-
diac arrest in one patient (5%) and pulmonary embolism in
one patient(5%) of group I, while in group II septic shock
due to nosocomial pneumonia in two patients (10%), refrac-
tory hypoxemia in two patients (10%), cardiac arrest led to
death in three patients (15%) and pulmonary embolism in
two patients (10%).
Analysis of survival
Cumulative mortality in the ICU after study entry in the two
groups (Fig. 3)
Most of ICU deaths occurred between 20 and 24 days after
study entry, almost 27% of group II died between days 4
and 6 after randomization, compared with only 10% of group
I.
Univariate analyses and multivariate analyses of intensive care
unit and 30 days survival (Table 5 and 6)
Independent risk factors that signiﬁcantly correlated with de-
creased ICU survival and also decreased 30 day survival were
conventional weaning approach (p= 0.041) and advanced age
(P65 years) (i.e. the number of death in the ICU was more in
patients weaned by conventional mode and those aged
P65 years), the number of patients aged P65 years was 7
(35%) in group I versus 10 (50%) in group II (p= 0.033).
Complications during weaning in the two studied groups
The incidence of nosocomial pneumonia was signiﬁcantly
higher in group II compared to group I. The chest X-rays in
group I show no inﬁltrates while in group II they show bilat-
eral inﬁltrates in 7 (35%) patients (p= 0.004), the total leuco-
cytic count (TLC) cell/mm3 was signiﬁcantly higher in group II
compared to group I (11,390 ± 1386.1) versus (6878 ± 7587)
(p= 0.003). Other complications such as bed sores, urinary
tract infection, GIT bleeding and pneumothorax were higher
in group II compared to group I (p< 0.05).Table 1 Baseline characteristic of patients during mechanical ventilation.
Group I (mean ± SD) Group II (mean ± SD) P-value
Age (years) 64.7 ± 3.6 65.8 ± 6.2 0.521
Smoking index (Pack/year) 40 ± 3.25 40 ± 2.98 0.847
Heart Rate (Beat/min) 130 ± 7.25 129 ± 8.58 0.475
R.R (cycle/min) 31.15 ± 10.03 29.50 ± 10.5 0.963
Temperature (C) 36.8 ± 0.39 36.75 ± 0.41 0.865
Systolic blood pressure (mm Hg) 122.5 ± 11.04 111.5 ± 9.7 0.225
Diastolic blood pressure (mm Hg) 75 ± 18.4 71 ± 18.03 0.159
Table 2 criteria of ﬁtness for spontaneous breathing trial (SBT).
Group I (mean ± SD) Group II (mean ± SD) P-value
PaO2 (mm Hg) 61.7 ± 2.09 62.75 ± 2.09 0.999
O2 sat% 91 ± 2.17 92 ± 2.17 0.999
FIO2 (%) 35%± 5% 34%± 5% 0.909
Temperature(C) 36.94 ± 0.29 36.80 ± 0.29 0.999
Glasgow coma score 13.95 ± 0.78 13.90 ± 0.71 0.832
Table 3 Parameters of the studied groups during spontaneous breathing trial failure.
Group I (mean ± SD) Group II (mean ± SD) P-value
R.R (cycle/min) 42 ± 2.05 41.2 ± 1.8 0.935
Tidal volume (L) 0.480 ± 0.133 0.490 ± 0.131 0.756
RSBI (Breaths/min/liter) 110 ± 10.52 115 ± 10.68 0.587
Heart rate (beat/min) 122.5 ± 8.50 129.25 ± 12.06 0.048
Systolic blood pressure (mm Hg) 112.5 ± 13.32 116 ± 12.7 0.223
Diastolic blood pressure (mm Hg) 75 ± 5.12 75.5 ± 5.10 0.428
SpO2 (%) 88.25 ± 1.55 86.5 ± 2.1 0.635
Disturbed Conscious level 12(60%) 17(85%) 0.063
Agitation 20(100%) 20(100%) 0.999
Diaphoresis 20(100%) 20(100%) 0.999
Thoracic abdominal paradoxical movement 20(100%) 20(100%) 0.999
Table 4 Weaning outcome variables in the two studied groups.
Group I Group II P-value
Duration of weaning in hours mean ± SD 35 ± 1.63 47 ± 2.25 0.044*
Duration of ICU stay (in days) mean ± SD 9.50 ± 3.2 11.4 ± 2.70 0.049*
Number of deaths in ICU n (%) 3 (15%) 5 (25%) 0.031*
Number of deaths at 30 days n (%) 5 (25%) 9 (45%) 0.008**
* P< 0.05: signiﬁcant.
** P< 0.01: highly signiﬁcant.
Figure 3 Cumulative mortality in the ICU after study entry in
the two studied groups.
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Non invasive ventilation is an effective tool for facilitating
weaning in patients with acute or chronic respiratory failure,
mainly patients with COPD [11]. One study has reported a de-
crease in the use of SIMV, especially alone without PS [12].Although the use of SIMV as a weaning mode may be decreas-
ing, it remains a commonly used mode for ventilatory support
in recent study [13]. One recent study which was carried out in
55 ICUs in Australia and New Zealand revealed that SIMV,
with or without PS, is the mode preferred by specialists in that
region. However, their survey did not clarify the reasons for
the popularity of this ventilator mode [14].
In the present study, the mean value of duration of weaning
in hours was signiﬁcantly lower in group I compared to group
II (35 ± 1.63 versus 47 ± 2.25) (p= 0.044).
Some studies [15–17] stated that weaning with NIV was
associated with a shorter duration of weaning than the invasive
group. Burns et al. 2006 [18] also found that compared to inva-
sive weaning, NIV was associated with shorter mechanical ven-
tilation (by 7.33 days). Some authors [19] concluded that NIV
reduces the duration of mechanical ventilation and the inci-
dence of complications associated with prolonged mechanical
ventilation, these results are in agreement with the present
study.
Two studies [20,21] showed that SIMV was associated with
signiﬁcant increase in weaning duration compared with daily
T-piece trials or gradual reductions in pressure support.
On the other hand, Shiva et al. 2009 [8] reported that there
was no signiﬁcant difference in the time spent on mechanical
ventilation between NIV and pressure support ventilation
Table 5 Univariate analyses of intensive care unit and 30 days survival.
Adjusted odds ratio 95% CI p value
Decreased ICU survival Univariate analysis
Conventional-weaning approach 6.4 1.2–35.6 0.041*
Age >65 years 5.9 1.3–30.4 0.033*
Gender 1.20 1.07–1.32 0.055
GCS 14.2 13.8–15.2 0.088
RSBI(breaths/L/min) 19.5 18.62–22.9 0.092
FIO2 11.1 10.2–12.5 0.142
Decreased 30-days survival Univariate analysis
Conventional-weaning approach – – 0.042*
Age P65 years – – 0.049*
Gender 1.23 1.17–1.30 0.093
GCS 14.9 13.3–15.8 0.091
RSBI(breaths/L/min) 20.4 18.74–22.5 0.090
FIO2 11.5 10.1–12.2 0.140
CI: conﬁdence interval.
* P< 0.05: signiﬁcant.
Table 6 Multivariate analyses of intensive care unit and 30 day survival.
Adjusted odds ratio 95% CI p Value
Decreased ICU survival Multivariate analysis
Conventional-weaning approach 6.3 1.2–35.6 0.04*
Age >65 years 4.8 1.4–14.3 0.014*
GCS 14.9 14.8–17.2 0.068
RSBI(breaths/L/min) 19.5 17.62–22.2 0.091
FIO2 11.8 11.2–12.2 0.199
Decreased 30-days survival
Conventional-weaning approach 3.11 1.2–8.7 0.019*
Age >65 years 4.9 1.4–14.3 0.014*
GCS 14.9 14.8–17.2 0.9
RSBI (breaths/L/min) 19.5 16.60–24.2 0.079
FIO2 11.6 11.11–13.17 0.138
CI: conﬁdence interval.
* P< 0.05: signiﬁcant.
164 W.S. El-Shimy et al.group (PSV).This may be explained by the difference between
the two studies as in the present study, NIV is in comparison to
SIMV with pressure support not pressure support alone. Gira-
ult et al. 2011 [22] randomized 208 patients with chronic hyper-
capnic respiratory failure intubated for acute respiratory
failure (ARF) who failed the ﬁrst spontaneous breathing trial
into three groups: conventional invasive weaning group (69 pa-
tients), NIV (69 patients) or extubation followed by standard
oxygen therapy (70 patients). They reported that NIV was
associated with a longer weaning time than in the invasive
group (2.5 versus 1.5 days; P= 0.033).
In the present study the mean value of duration of ICU stay
in days was signiﬁcantly lower in group I (9.50 ± 3.2) com-
pared to group II (11.4 ± 2.70) (p= 0.049). Recent studies
[17,18,23] stated that NIV was associated with signiﬁcant
reductions in the duration of stay in the ICU, this is in agree-
ment with this study.On the other hand, some studies [24,25] revealed that no
difference was detected in the duration of ICU stay between
NIV and conventional weaning with pressure support.
In the present study the number of deaths in the ICU days
was signiﬁcantly lower (3; 15%) in group I compared to (5;
25%) group II (p= 0.031). In accordance with the present
study, Nava et al. 2005 [26] randomized patients with COPD
with recurrent spontaneous breathing T piece (SBT) trial fail-
ure, concluded that the use of NIV post extubation was asso-
ciated with lower ICU mortality. Also, some studies [27–29]
reported that weaning using NIV signiﬁcantly reduced mortal-
ity and nosocomial pneumonia.
Recently, Ortiz et al. 2010 [30] observed that patients ven-
tilated continually with SIMV with PS had a lower mortality
than patients initially ventilated with SIMV with PS and later
switched to assisted control ventilation (A/C), or those venti-
lated continually with A/C.
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ences in complications, ICU or hospital stay between NIV and
conventional weaning groups.
In the present study, there was a signiﬁcant reduction in the
number of deaths at 30 days in the group I (5; 25%) compared
to (9; 45%) in group II.
Unlike the results of this study, Ferrer et al. 2006 [27] stated
that there was no signiﬁcant difference in 90 days mortality be-
tween NIV and the invasive weaning. Also, Shiva et al. 2009 [8]
documented that there were no signiﬁcant statistical difference
in the number of deaths at 30 days between patients weaned by
NIV and PSV (pressure support ventilation).
In the present study, there was signiﬁcant reduction in the
number of complications in the ICU in group I in comparison
to group II, in group II seven patients (35%) had nosocomial
pneumonia, four patients (20%) developed pneumothorax and
ﬁve (20%) had GIT bleeding, these complications were not re-
ported in group I.
Complications are more common when mechanical ventila-
tion is prolonged which usually occurs when using the invasive
mode of weaning [4]. With noninvasive ventilator technique,
the risk for aspiration of colonized or infected oropharyngeal
secretions is probably smaller, because there is no tracheal
prosthesis. The patient can expectorate freely and the vocal
cords are not kept open, while with invasive ventilation, an
endotracheal tube can predispose to the development of pneu-
monia by impairing cough and mucociliary clearance [31].
Some studies [5,18] stated that patients weaned by NIV had
less incidence of nosocomial pneumonia compared to those
weaned by the conventional weaning method. Another study
[25] stated that the percentage of complications in the NPPV
group was lower (28.6% versus 75.7%), with a lower incidence
of pneumonia (3.6% versus 45.9%) than in the invasive venti-
lation group. These results led the authors to conclude that
early extubation and NPPV is a valid alternative for ventila-
tion in a group of heterogeneous patients that initially failed
in weaning.
In addition Hess et al. 2007 [32] concluded that the use of
NPPV is strongly recommended to allow early extubation in
patients with COPD who failed a spontaneous breathing trial.
Some studies [33,34] reported that NIV decreased the risk of
infection (ventilator associated pneumonia) and the need for
sedation, which are factors that increase the duration of
mechanical ventilation.
On the other hand, Girault et al. 2003 [24] reported that
there were no differences in weaning failure or complications
between NIV and the conventional weaning group.
In the present study, the causes that led to death within
30 days after entry in the study included, in group I refractory
hypoxemia, cardiac arrest, and pulmonary embolism, while in
group II septic shock due to nosocomial pneumonia, refrac-
tory hypoxemia, cardiac arrest and pulmonary embolism. This
is in accordance with the results obtained by Ferrer et al. 2003
[17] who reported that the causes of death within 90 days after
entry in the study were septic shock/multiple organ failure in
one patient in the NIV group and 9 in the conventional group,
refractory hypoxemia in one patient in the NIV group and two
in the conventional group, cardiac arrest in two patients in the
NIV group and one in the conventional group, pneumothorax
in one patient in the conventional group and pulmonary embo-
lism in one patient in the conventional group.In the present study, Independent risk factors signiﬁcantly
correlated with decreased ICU and 30 day survival were con-
ventional weaning approach (p= 0.041) and advanced age
(P65 years) (p= 0.033).
Some authors [18] stated that the conventional weaning ap-
proach was an independent risk factor of decreased ICU
(p= 0.035) and 90 day survival (p= 0.018). They also stated
that the conventional weaning approach (p= 0.018) together
with advanced age (P70 years) and hypercapnia (PaCO2
P45 mm Hg) were independent factors signiﬁcantly associated
with decreased 90 day survival (p= 0.003). These results are
consistent with the results of the current study, despite doing
univariate and multivariate analyses for decreased 90 day sur-
vival, while in this study only 30 day survival was seen.
On the other hand, a single recent study [22] documented
that no signiﬁcant difference was found in hospital survival be-
tween NIV and conventional ventilation as weaning modes.
In the present study weaning was successful in 17(85%) and
15(75%) patients in group I and II respectively, It was signif-
icantly higher in group I compared to group II (p= 0.049). On
the other hand, Burns et al. 2006 [18] reported that there was
no difference in weaning success between NIV and conven-
tional weaning.
The success of NIV is probably related to its ability to re-
verse the underlying pathophysiology of ARF; which is de-
scribed as an imbalance between respiratory load and
capacity. NIV can decrease rapid shallow breathing, improve
gas exchange, improve alveolar ventilation, and decrease the
work of breathing [35].
In conclusion, weaning of COPD patients with respiratory
failure by noninvasive positive pressure ventilation (NIPPV)
had a better outcome compared with the conventional weaning
method. Noninvasive positive pressure ventilation permits ear-
lier removal of the endotracheal tube, reduces weaning time,
stay in the intensive care unit, decreases the incidence of noso-
comial pneumonia and improves 30 day survival rates. There-
fore, NIV should be the preferred weaning strategy for patients
with COPD especially those with difﬁculty in weaning.
References
[1] S. Dolan, B. Varkey, Prognostic factors in chronic obstructive
pulmonary disease, Curr. Opin. Pulm. Med. 11 (2005) 149–152.
[2] Y. Peigang, J. Marini, Ventilation of patients with asthma and
chronic obstructive pulmonary disease, Curr. Opin. Crit. Care 8
(2002) 70–76.
[3] I. Matic´, D. -Danic´, V.M. Kogler, M. Jurjevic´, I. Mirkovi, M.N.
Vucˇinic´, Chronic obstructive pulmonary disease and weaning of
difﬁcult-to-wean patients from mechanical ventilation, Croat.
Med. J. 48 (2007) 51–58.
[4] S. Epstein, Complications in ventilator supported patients, in:
M. Tobin (Ed.), Principles and Practice of Mechanical
Ventilation, McGraw Hill, New York, 2006, pp. 877–902.
[5] C.E. Trevisan, S.R. Vieiraand the Research Group in
Mechanical Ventilation Weaning, Noninvasive mechanical
ventilation may be useful in treating patients who fail weaning
from invasive mechanical ventilation, Crit. Care 12 (2) (2008).
[6] P. Prakash, K. Krishna, P. Singh, Weaning modes in mechanical
ventilation, Indian Acad. Clin. Med. 8 (3) (2007) 222–225.
[7] J. Rathgeber, B. Schorn, V. Falk, S. Kazmaier, T. Spiegel, H.
Burchardi, The inﬂuence of controlled mandatory ventilation
(CMV), intermittent mandatory ventilation (IMV) and biphasic
intermittent positive airway pressure (BIPAP) on duration of
166 W.S. El-Shimy et al.intubation and consumption of analgesics and sedatives, Eur. J.
Anaesthesiol. 14 (6) (1997) 576–582.
[8] B.N. Shiva, D. Chaudhry, R. Khanna, Role of non invasive
ventilation in weaning from mechanical ventilation in patients of
chronic obstructive pulmonary disease an indian experience,
Indian J. Crit. Care Med. 13 (4) (2009) 207–212.
[9] P.K. Plant, J.L. Owen, M.W. Elliott, Early use of non-invasive
ventilation for acute exacerbations of chronic obstructive
pulmonary disease on general respiratory wards: a multicentre
randomised controlled trial, Lancet 355 (2000) 1931–1935.
[10] P.H. Kuo, H.D. Wu, B.Y. Lu, M.T. Chen, S.H. Kuo, P.C.
Yang, Predictive value of rapid shallow breathing index
measured at initiation and termination of a 2 hour
spontaneous breathing trial for weaning outcome in ICU
patients, J. Formos. Med. Assoc. 105 (5) (2006) 390–398.
[11] S.K. Epstein, C.G. Durbin, Should a patient be extubated and
placed on non invasive ventilation after failing a spontaneous
breathing trial?, Respir Care 55 (2) (2010) 198–208.
[12] A. Esteban, A. Anzueto, F. Frutos, A. Inmaculada, L.
Brochard, T. Stewart, S. Benito, K. Scott, et al, JAMA (2002)
287–345.
[13] A. Esteban, N.D. Ferguson, M.O. Meade, et al, Evolution of
mechanical ventilation in response to clinical research, Am. J.
Respir. Crit. Care Med. 177 (2) (2008) 170–177.
[14] L. Rose, J.J. Presneill, L. Johnston, S. Nelson, J.F. Cade,
Ventilation and weaning practices in Australia and New
Zealand, Anaesth. Intensive Care 37 (1) (2009) 99–107.
[15] J. Chen, D. Qiu, D. Tao, Time for extubation and sequential
noninvasive mechanical ventilation in COPD patients with
exacerbated respiratory failure who received invasive
ventilation, Zhonghua Jie He He Hu Xi Za Zhi 24 (2) (2001)
99–100.
[16] D. Hess, Ventilator modes used in weaning, Chest 120 (2001)
474–476.
[17] M. Ferrer, A. Esqinas, F. Arancibia, et al, Noninvasive
ventilation during persistent weaning failure, Am. J. Respir.
Crit. Care Med. 168 (2003) 70–76.
[18] K.E. Burns, N.K. Adhikari, M.O. Meade, A meta-analysis of
noninvasive weaning to facilitate liberation from mechanical
ventilation, Can. J. Anaesth. 53 (3) (2006) 305–315.
[19] H.M. EL-Gendy, H.M. Bahr, GH.A. Attia, Non invasive
ventilation versus conventional mechanical ventilation as a
weaning technique in acute on top of chronic obstructive
pulmonary disease, Egypt. J. Chest (2006) 64–72.
[20] L. Brochard, A. Rauss, S. Benito, et al, Comparison of three
methods of gradual withdrawal from ventilatory support during
weaning from mechanical ventilation, Am. J. Respir. Crit. Care
Med. 150 (1994) 896–903.
[21] A. Esteban, F. Frutos, M.J. Tobin, et al, A comparison of four
methods of weaning patients from mechanical ventilation, N.
Engl. J. Med. (1995) 345–350.
[22] C. Girault, M. Bubenheim, J.L. Diehl, S. Elatrous, J.
Richecoeur, et al, Noninvasive ventilation and weaning in
patients with chronic hypercapnic respiratory failure: a
randomized multicenter trial, Am. J. Respir. Crit. Care Med.
184 (6) (2011) 672–679.[23] G.M. Rabie, A.Z. Mohamed, R.N. Mohamed, Noninvasive
ventilation in the weaning of patients with acute-on-chronic
respiratory failure due to COPD, Chest 126 (4) (2004) 755.
[24] C. Girault, A. Chajara, F. Dachraoui, et al, Non-invasive
ventilation during mechanical ventilation weaning in chronic
respiratory failure patients. A prospective randomised
controlled and multicenter trial [in French], Rev. Mal. Respir.
20 (2003) 940–945.
[25] M. Antonelli, G. Bello, Noninvasive mechanical ventilation
during the weaning process: facilitative, curative, or preventive?,
Crit Care 12 (2008) 136.
[26] S. Nava, C. Gregoretti, F. Fanfulla, E. Squadrone, M. Grassi,
A. Carlucci, et al, Noninvasive ventilation to prevent
respiratory failure after extubation in high-risk patients, Crit.
Care Med. 33 (11) (2005) 2465–2470.
[27] M. Ferrer, M. Valencia, J.M. Nicolas, O. Bernadich, J.R. Badia,
A. Torres, Early non-invasive ventilation averts extubation
failure in patients at risk. A randomized trial, Am. J. Respir.
Crit. Care Med. 173 (2) (2006) 164–170.
[28] R. Agarwal, A.N. Agarwal, D. Gupta, S.K. Jindal, Role of
noninvasive positive-pressure ventilation in post extubation
respiratory failure: a meta-analysis, Respir. Care 52 (11) (2007)
1472–1479.
[29] K.E. Burns, N.K. Adhikari, S.P. Keenan, M. Meade, Use of
noninvasive ventilation to wean critically ill adults off invasive
ventilation: meta analysis and systematic review, BMJ 338
(2009) 1574.
[30] G. Ortiz, F. Frutos-Vivar, N.D. Ferguson, A. Esteban, K.
Raymondos, C. Apezteguı´a, J. Hurtado, M. Gonza´lez, V.
Tomicic, J. Elizalde, F. Abroug, Y. Arabi, P. Pelosi, A.
Anzueto, Outcomes of patients ventilated with synchronized
intermittent mandatory ventilation with pressure support: a
comparative propensity score study, Chest 137 (6) (2010) 1265–
1277.
[31] S. Keenan, C. Powers, G. McCormack, G. Block, Non invasive
positive pressure ventilation for post extubation respiratory
distress: a randomized trial, JAMA 287 (2002) 3238–3244.
[32] D.R. Hess, H.T. Stelfox, U. Schmidt, Noninvasive Positive-
Pressure Ventilation: A Silver Bullet for Extubation Failure?,
Respir. Care 52 (11) (2007) 1454–1456.
[33] E. Girou, F. Schortgen, C. Delclaux, C. Brun-Buisson, F. Blot,
Y. Lefort, et al, Association of noninvasive ventilation with
nosocomial infections and survival in critically ill patients,
JAMA 284 (18) (2000) 2361–2367.
[34] E. Girou, C. Brun-Buisson, S. Taille´, F. Lemaire, L. Brochard,
Secular trends in nosocomial infections and mortality associated
with noninvasive ventilation in patients with exacerbation of
COPD and pulmonary edema, JAMA (2003) 290.
[35] M. Vitacca, N. Ambrosino, E. Clini, et al, Physiologic response
to pressure support ventilation delivered before and after
extubation in patients not capable of totally spontaneous
autonomous breathing, Am. J. Respir. Crit. Care Med. 164
(2001) 638–641.
